Biotechnology
Company Overview of aTyr Pharma Inc.
Key Executives for aTyr Pharma Inc.
| Name | Board Relationships | Title | Age |
| John D. Mendlein Ph.D., J.D. | 67 Relationships | Executive Chairman and Chief Executive Officer | 52 |
| Paul R. Schimmel Ph.D. | 86 Relationships | Founder and Director | 71 |
aTyr Pharma Inc. Board Members*
| Name | Board Relationships | Primary Company | Age |
| John D. Mendlein Ph.D., J.D. | 67 Relationships | aTyr Pharma Inc. | 52 |
| Paul R. Schimmel Ph.D. | 86 Relationships | Metabolon, Inc. | 71 |
| David H. Mack Ph.D. | 62 Relationships | Alta Partners LP | -- |
| Amir H. Nashat Ph.D., Sc.D | 131 Relationships | Living Proof, Inc. | 39 |
| John K. Clarke | 133 Relationships | Alnylam Pharmaceuticals, Inc. | 58 |
aTyr Pharma Inc. Executive Committees*
| Committee Name | Chairperson | Board Relationships | Members | |
| There is no committee data available. | ||||

CEO COMPENSATION IN THIS INDUSTRY
| Industry Range | ||
| Salary | 373.3K | |
| Bonus | 262.1K | |
| Total Short Term Compensation | 461.9K | |
| Total Value of Options | 13.3M |
INDUSTRY EXECUTIVE CHANGES
Post a JobJobs
- Chicago, IL | DunnhumbyusaPosted: Jun 18
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
Sponsored Financial Commentaries
Sponsored Links
To contact aTyr Pharma Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








